CA Patent

CA2858096C — Pyrazolo[1,5-a]pyrimidines as antiviral agents

Assigned to Gilead Sciences Inc · Expires 2020-06-23 · 6y expired

What this patent protects

Compounds of Formula I, or pharmaceutically acceptable salts thereof are provided: (see formula I) The compounds of Formula I, or pharmaceutically acceptable salts thereof, are useful for the treatment of Pneumovirinae virus infections, including Human respiratory syncytial virus…

USPTO Abstract

Compounds of Formula I, or pharmaceutically acceptable salts thereof are provided: (see formula I) The compounds of Formula I, or pharmaceutically acceptable salts thereof, are useful for the treatment of Pneumovirinae virus infections, including Human respiratory syncytial virus infections.

Drugs covered by this patent

Patent Metadata

Patent number
CA2858096C
Jurisdiction
CA
Classification
—
Expires
2020-06-23
Drug substance claim
No
Drug product claim
No
Assignee
Gilead Sciences Inc
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.